One recent review noted that, although most AI efforts have focused on histopathology images, commercialized models have been used extensively for automated Papanicolaou test screening.1 Efforts have expanded on whole slide images in both gynecologic and nongynecologic cytopathology as well. A 2022 article by researchers in Korea reviewed many of the latter applications, including thyroid, bladder, lung, breast, ovarian, pancreatic, prostate, and pleu-ral effusion cancers. Most of the studies focused on classification and segmentation tasks, the authors found. They concluded that "although most of the studies showed impressive results, the sizes of the training and validation datasets were limited."
展开▼
